Prognostic significance of CD30 expression in nasal natural killer/T-cell lymphoma
Guan‐Nan Wang(First Affiliated Hospital of Zhengzhou University), Wencai Li(First Affiliated Hospital of Zhengzhou University), Ye Li(Nanjing University of Chinese Medicine), Mingzhi Zhang(Chinese Academy of Sciences), Dandan Zhang(Qingdao University), Zhen Li(Sun Yat-sen University), Lei Zhang(First Affiliated Hospital of Zhengzhou University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Wugan Zhao(First Affiliated Hospital of Zhengzhou University), Xianzheng Gao(First Affiliated Hospital of Zhengzhou University), Xiangyu Zheng(First Affiliated Hospital of Zhengzhou University), Ling Li(First Affiliated Hospital of Zhengzhou University), Jun Zhou(First Affiliated Hospital of Zhengzhou University)
Cited by 16
Related Papers
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
|Cell stem cell|2018|980
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
|Nature Medicine|2024|452
Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain
|The American Journal of Human Genetics|2010|394
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2019|387
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296